About Finnadvance
Finnadvance is a company based in Oulu (Finland) founded in 2018 by Prateek Singh. Finnadvance has raised $1.9 million across 4 funding rounds from investors including European Union, Athensmed and Takoa Invest. Finnadvance offers products and services including AKITA® Plate, AKITA® Lid, and AKITA® Wave. Finnadvance operates in a competitive market with competitors including ACXEL, SpacePharma, Axbio, Accel Diagnostics and Micronit, among others.
- Headquarter Oulu, Finland
- Founders Prateek Singh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Finnadvance Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.9 M (USD)
in 4 rounds
-
Latest Funding Round
$1.3 M (USD), Seed
Apr 08, 2022
-
Investors
European Union
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Finnadvance
Finnadvance offers a comprehensive portfolio of products and services, including AKITA® Plate, AKITA® Lid, and AKITA® Wave.
High-throughput platform for in-vitro drug testing models
Enables simultaneous TEER measurements in tissue cultures
Optimized device for compatible microfluidic research
People of Finnadvance
Unlock access to complete
Funding Insights of Finnadvance
Finnadvance has successfully raised a total of $1.9M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.3 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Finnadvance
Finnadvance has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Union, Athensmed and Takoa Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A Finnish family-owned investment company focused on growth-oriented businesses.
|
Locked | Locked | Locked | |
|
Funding is provided for deep tech ventures in Nordics.
|
Locked | Locked | Locked |
Investor details for Finnadvance
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Finnadvance
Investment portfolio details for Finnadvance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Finnadvance
Detailed financials for Finnadvance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Finnadvance Comparisons
Peer comparison for Finnadvance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Finnadvance
Finnadvance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACXEL, SpacePharma, Axbio, Accel Diagnostics and Micronit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microfluidic technology and solutions are provided for life sciences industries.
|
|
| Locked | Locked | Locked |
Microgravity research solutions are provided for researchers and companies.
|
|
| Locked | Locked | Locked |
Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI
|
|
| Locked | Locked | Locked |
Protein biomarkers are analyzed via lab-on-chip platform for disease monitoring.
|
|
| Locked | Locked | Locked |
Microfluidic devices and lab-on-chip solutions are designed and manufactured.
|
|
| Locked | Locked | Locked |
Developer of microfluidic chip and technology for life science research
|
Detailed competitors of Finnadvance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Finnadvance
Complete news archive for Finnadvance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Finnadvance
Finnadvance was founded in 2018.
Finnadvance is headquartered in Oulu, Finland. It is registered at Oulu, North Ostrobothnia, Finland.
Prateek Singh is the current CEO of Finnadvance. They have also founded this company.
Finnadvance is a funded company, having raised a total of $1.9M across 4 funding rounds to date.
Finnadvance was founded in 2018 in Oulu, Finland, within the biotechnology sector. Microfluidics and microtechnology are utilized to create high-throughput biological barrier models on chips. These models replicate human tissues, including vascular, lung, and blood-brain barriers, for evaluating small molecule and nano-formulation permeability and toxicity. Dynamic cell cultures are employed to simulate in-vivo conditions, supporting drug development processes.
Finnadvance's top competitors include Noul, Suzhou Akso Biotechnology and Axbio.
Finnadvance offers AKITA® Plate, AKITA® Lid, and AKITA® Wave.
Finnadvance has 7 investors. Key investors include European Union, Athensmed, Takoa Invest, Voima Ventures, and Icebreaker.vc.